INS-IGF2 Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)
-
- Antigène Tous les produits INS-IGF2
- INS-IGF2 (INS-IGF2 Readthrough (INS-IGF2))
- Type de proteíne
- Recombinant
- Attributs du protein
- Transcript Variant 2
- Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette INS-IGF2 protéine est marqué à la Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Attributs du produit
-
- Recombinant human INS-IGF2 readthrough transcript (INS-IGF2), transcript variant 2 (transcript variant 2) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Pureté
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
-
-
- Indications d'application
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Commentaires
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Stock
- -80 °C
- Stockage commentaire
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Antigène
- INS-IGF2 (INS-IGF2 Readthrough (INS-IGF2))
- Autre désignation
- Ins-Igf2 Readthrough Transcript (Ins-Igf2) (INS-IGF2 Produits)
- Synonymes
- INSIGF Protein, INS-IGF2 readthrough Protein, INS-IGF2 Protein
- Sujet
- This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye.
- Poids moléculaire
- 21.4 kDa
- NCBI Accession
- NP_001035835
- Pathways
- Peptide Hormone Metabolism
-